In vivo evaluation of vascular-targeted spheroidal microparticles for imaging and drug delivery application in atherosclerosis
- 1 November 2014
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 237 (1) , 279-286
Abstract
No abstract availableKeywords
Funding Information
- American Heart Association (10IRG3490015)
- NSF CAREER (CBET1054352)
This publication has 39 references indexed in Scilit:
- Margination Propensity of Vascular-Targeted Spheres from Blood Flow in a Microfluidic Model of Human MicrovesselsLangmuir, 2013
- Particle-cell dynamics in human blood flow: Implications for vascular-targeted drug deliveryJournal of Biomechanics, 2012
- Nanomedicine for the prevention, treatment and imaging of atherosclerosisNanomedicine: Nanotechnology, Biology and Medicine, 2012
- Perspectives and opportunities for nanomedicine in the management of atherosclerosisNature Reviews Drug Discovery, 2011
- Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review)Molecular Membrane Biology, 2010
- Flow and adhesion of drug carriers in blood vessels depend on their shape: A study using model synthetic microvascular networksJournal of Controlled Release, 2010
- Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriersBiomaterials, 2010
- Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?Pharmaceutical Research, 2008
- The adhesive strength of non-spherical particles mediated by specific interactionsBiomaterials, 2006
- Vascular Targeting: Recent Advances and Therapeutic PerspectivesTrends in Cardiovascular Medicine, 2006